ThoraxCenter, Erasmus Medical Center, Rotterdam, The Netherlands.
EuroIntervention. 2013 Sep 10;9 Suppl:S84-90. doi: 10.4244/EIJV9SSA16.
Cumulative evidence has demonstrated that transcatheter aortic valve implantation (TAVI) constitutes an effective treatment option for patients with severe symptomatic aortic stenosis and a high operative risk. New valve designs and TAVI-enabling devices have simplified the procedure, reduced the risk of complications, and broadened the applications of this treatment. The global adoption of TAVI allows us to appreciate the advantages, potentialities and caveats of the technology, identify patients who would benefit from TAVI and stratify more accurately the risk of complications. The focus of this article is to discuss the advances in this field, present the current evidence, and highlight the developments and strategies proposed to address the limitations of TAVI treatment.
已有大量证据表明，经导管主动脉瓣置换术（TAVI）是一种有效的治疗方法，适用于有严重症状性主动脉瓣狭窄且手术风险高的患者。新的瓣膜设计和 TAVI 启用设备简化了手术过程，降低了并发症风险，并拓宽了该治疗方法的应用范围。TAVI 在全球范围内的应用使我们能够了解该技术的优势、潜力和注意事项，确定哪些患者将从 TAVI 中受益，并更准确地分层并发症风险。本文的重点是讨论该领域的进展，介绍目前的证据，并强调为解决 TAVI 治疗的局限性而提出的发展和策略。
